Moody's News
Most Popular Moody's Story
Pharma is cash rich abroad, but debt will rise
Amidst consistent reports that there is plenty of cash in the U.S. pharmaceutical industry, analysts are fretting about the challenges of accessing that cash--due to the serious tax implications--for Read more...
Latest Headlines
- May 24, 2010
- April 16, 2010
- November 20, 2009
- October 15, 2008
- October 10, 2008
- September 11, 2008
- June 25, 2008
- June 4, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
